Dennis Chookaszian
Known title: DirectorCIK: 0001120026
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
CME Launches New Crypto Futures as Rate Hike Odds Shift. CME Group is launching new futures contracts for Uniswap and Bitcoin Cash, expanding its cryptocurrency portfolio. At the same time, the exchange's policy stance has shifted odds on Polymarket regarding future interest rate hikes. These developments occur as the market prepares for CME's upcoming third-quarter earnings report.
Transaction History
| PRDO | ▲ Buy | Grant | 3,987 | $0 | 5/21/2026 | View on chart |
| PRDO | ▲ Buy | Option Exercise | 21,129 | $126K | 3/12/2026 | View on chart |
| PRDO | ▲ Buy | Grant | 5,155 | $0 | 5/22/2025 | View on chart |
| PRDO | ▲ Buy | Option Exercise | 26,664 | $105K | 3/6/2025 | View on chart |
| PRDO | ▲ Buy | Grant | 6,256 | $0 | 5/23/2024 | View on chart |
| PRDO | ▲ Buy | Grant | 7,827 | $0 | 5/25/2023 | View on chart |
| PRDO | ▲ Buy | Option Exercise | 16,000 | $45K | 3/14/2023 | View on chart |
| CME | ▲ Buy | Grant | 693 | $145K | 6/27/2022 | View on chart |
| PRDO | ▲ Buy | Grant | 9,050 | $0 | 5/26/2022 | View on chart |
| PRDO | ▲ Buy | Option Exercise | 16,000 | $104K | 3/7/2022 | View on chart |
| CME | ▲ Buy | Grant | 47 | $0 | 1/25/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 24, 2026
Perdoceo Education (PRDO) Focuses on Healthcare Expansion and Cost Discipline
Recent analysis highlights Perdoceo's expansion into healthcare education as a potential value driver. Commentators note that growth in the USAHS segment and strict cost management support a positive outlook for the company. These strategic moves are being watched closely by investors evaluating the stock's long-term positioning.
Perdoceo Education (PRDO) Focuses on Healthcare Expansion and Cost Discipline. Recent analysis highlights Perdoceo's expansion into healthcare education as a potential value driver. Commentators note that growth in the USAHS segment and strict cost management support a positive outlook for the company. These strategic moves are being watched closely by investors evaluating the stock's long-term positioning.